MolGenBio

MolGenBio: FK506 Derivative Hair Growth Drug

October 4, 2022 /

A new Korean biotech company seeks to leverage the multi-faceted therapeutic benefit of FK506 to create a newer and safer hair growth drug. As we are gratified to see completely new approaches emerge in the hair growth space, we should also value the strategy of creating new and improved iterations of older hair growth drugs…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.